Last month on the podcast, I spoke with experts about new minimally invasive approaches in treating chronic pain, off the shelf cell therapies and new therapeutic and trial designs in pediatric rare disease. Also check out a special Breakthrough episode hosted by Xtalks’ Corey Stanton, MD featuring a discussion on scalable biologics manufacturing.
From neuromodulation and nerve ablation in chronic pain to basket trial strategies and novel bone marrow-derived cell therapy approaches, these conversations show how cutting-edge research is translating into real-world care.
Check out this month’s featured conversation on YouTube, Apple Podcasts or Spotify.
In this special Breakthrough episode, join host Corey Stanton as he speaks with Omar Wahab, Vice President of Bioprocessing at Lonza, about how strategic upstream decisions can enable scalable biologics manufacturing that support manufacturing readiness, supply resilience and long-term commercial success.
Check out more episodes of the Xtalks Life Science Podcast on YouTube, Apple Podcasts or Spotify.
NeuroOne’s CEO Dave Rosa discusses minimally invasive approaches for neuromodulation and nerve ablation to treat conditions including chronic pain, epilepsy and enable drug delivery into the brain.
Ossium Health’s CEO Kevin Caldwell discusses novel approaches to translating off the shelf, donor-derived bone marrow therapies into clinical practice for applications in hematopoietic cell and organ transplantation.
Polaryx’s CEO Alex Yang shares the development of novel treatment approaches for rare pediatric lysosomal storage disorders and the application of robust, flexible clinical trial designs.